Structural and non-coding variants increase the diagnostic yield of clinical whole genome sequencing for rare diseases

AT Pagnamenta, C Camps, E Giacopuzzi, JM Taylor… - Genome medicine, 2023 - Springer
Background Whole genome sequencing is increasingly being used for the diagnosis of
patients with rare diseases. However, the diagnostic yields of many studies, particularly …

The yin and the yang of early classical pathway complement disorders

KE Sullivan - Clinical and experimental immunology, 2022 - academic.oup.com
The classical pathway of the complement cascade has been recognized as a key activation
arm, partnering with the lectin activation arm and the alternative pathway to cleave C3 and …

Bi-allelic MCM10 variants associated with immune dysfunction and cardiomyopathy cause telomere shortening

RM Baxley, W Leung, MM Schmit, JP Matson… - Nature …, 2021 - nature.com
Abstract Minichromosome maintenance protein 10 (MCM10) is essential for eukaryotic DNA
replication. Here, we describe compound heterozygous MCM10 variants in patients with …

[HTML][HTML] Venus: elucidating the impact of amino acid variants on protein function beyond structure destabilisation

MP Ferla, AT Pagnamenta, L Koukouflis… - Journal of Molecular …, 2022 - Elsevier
Exploring the functional effect of a non-synonymous coding variant at the protein level
requires multiple pieces of information to be interpreted appropriately. This is particularly …

Low-frequency inherited complement receptor variants are associated with purpura fulminans

PK Bendapudi, S Nazeen, J Ryu, O Söylemez… - Blood, 2024 - ashpublications.org
Extreme disease phenotypes can provide key insights into the pathophysiology of common
conditions, but studying such cases is challenging due to their rarity and the limited …

[HTML][HTML] Complement factor I: Regulatory nexus, driver of immunopathology, and therapeutic

TM Hallam, SJ Sharp, A Andreadi, D Kavanagh - Immunobiology, 2023 - Elsevier
Complement factor I (FI) is the nexus for classical, lectin and alternative pathway
complement regulation. FI is an 88kDa plasma protein that circulates in an inactive …

Complement factor I deficiency: a potentially treatable cause of fulminant cerebral inflammation

T Altmann, M Torvell, S Owens, D Mitra… - Neurology …, 2020 - AAN Enterprises
Objective To raise awareness of complement factor I (CFI) deficiency as a potentially
treatable cause of severe cerebral inflammation. Methods Case report with neuroradiology …

CNS Inflammation as the First Sign of Complement Factor I Deficiency: A Severe Myelitis Treated With Intense Immunotherapy and Eculizumab

V Massey, CTE Nguyen, T François… - Neurology …, 2023 - AAN Enterprises
Objectives Complement factor I (CFI) deficiency is a rare autosomal recessive inborn error of
immunity. In this report, we highlight that complete CFI deficiency may present with isolated …

Plasma C3d levels as a diagnostic marker for complete complement factor I deficiency

L Naesens, J Smet, SJ Tavernier… - Journal of Allergy and …, 2021 - jacionline.org
II CFI mutations result in normal FI protein expression but impaired FI function. Regardless of
the type of mutation, CFI deficiency will be either partial (residual FI function) in …

Screening for immunodeficiencies in children with invasive pneumococcal disease: six-year experience from a UK children's hospital

EM Bijker, EAL Bateman, J Trück, S Patel… - The Pediatric …, 2022 - journals.lww.com
Background: A previous study showed that investigation of children with invasive
pneumococcal disease (IPD) revealed an immunodeficiency in up to 10% of cases …